Dhanvantri Jeevan Rekha Ltd.

View in App
13.68 +0.65 ▲5.0%

01 December 2023, 04:01:00 PM
Volume: 1,318

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.djrl.org.in
Market Cap 5.61 Cr.
Enterprise Value(EV) 5.61 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -0.24 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-09
Industry PE 63.34 Trailing Twelve Months Ending 2023-09
Book Value / Share 22.32 Trailing Twelve Months Ending 2023-09
Price to Book Value 0.61 Calculated using Price: 13.68
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.41 Cr. 4,098,400 Shares
FaceValue 10
About Dhanvantri Jeevan Rekha Ltd.
Dhanvantri Jeevan Rekha, incorporated on June 11, 1993 is a multi speciality hospital providing reliable diagnostic and therapeutical services. We lay great emphasis on providing good nursing care and clean environment. Dhanvantri hospital has been on the fore front of providing state of art equipment and services in western UP since 1994.

Dhanvantri Jeevan Rekha Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Dhanvantri Jeevan Rekha Ltd. Performance

View details >>
1 Day
+4.99%
1 Week
+15.44%
1 Month
+28.69%
3 Month
+5.23%
6 Month
+2.09%
1 Year
+0.22%
2 Year
+47.10%
5 Year
-28.00%
10 Year
+47.41%

Dhanvantri Jeevan Rekha Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 14.25 10.75 5.68 7.10 0.44 -2.51 -14.69 5.31 -2.31
Return on Capital Employed (%) 21.14 16.71 11.79 7.91 1.97 -2.55 -16.37 7.40 -1.46
Return on Assets (%) 10.82 7.95 3.77 4.46 0.30 -1.76 -10.03 3.51 -1.54

Dhanvantri Jeevan Rekha Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 8 9 10 11 11 10 9 10 9 9
Non Curr. Liab. 1 1 2 3 1 1 2 2 2 2
Curr. Liab. 2 2 4 3 3 3 3 3 3 4
Minority Int.
Equity & Liab. 11 13 16 16 15 15 14 14 14 14
Non Curr. Assets 7 8 13 13 13 12 11 11 10 10
Curr. Assets 4 4 3 3 3 3 2 4 4 4
Misc. Exp. not W/O
Total Assets 11 13 16 16 15 15 14 14 14 14

Dhanvantri Jeevan Rekha Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 8 9 11 14 17 18 10 17 18 19
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 8 10 12 14 17 18 10 17 18 20
Total Expenditure -6 -8 -10 -12 -16 -18 -11 -15 -17 -19
PBIDT 2 2 2 2 1 1 -1 2 1 1
Interest 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 -1 -1 -1 -1 -1 -1 -1
Taxation 0 0 0 0 0 0 0 0 0 0
Exceptional Items
PAT 1 1 1 1 0 0 -1 0 0 0
Adjusted EPS 3 2 1 2 0 -1 -3 1 -1 0

Dhanvantri Jeevan Rekha Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 1 1 1 4 1 1 1 0 1 0
Cash Fr. Inv. -1 -1 -1 -4 -1 0 0 0 -1
Cash Fr. Finan. 0 0 1 0 -2 0 0 0
Net Change 0 0 0 0 0 -1 1 0 1 -1
Cash & Cash Eqvt 0 0 1 1 1 0 1 1 2 1

Dhanvantri Jeevan Rekha Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 19.77 19.77 19.77 19.77 19.77 19.77 19.77 19.65 19.65
Public 80.23 80.23 80.23 80.23 80.23 80.23 80.23 80.35 80.35
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Dhanvantri Jeevan Rekha Ltd. Announcements

View details >>
Tue, 14 Nov 2023
Revised Outcome Of The Board Meeting Held On 11.11.2023
Revised outcome of the board meeting held on 11.11.2023 the board meeting commencement at 01:00 Pm and concluded at 02:00 Pm
Mon, 13 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
NEWSPAPER PUBLICATION OF THE RESULT 30TH SEPT 2023
Sat, 11 Nov 2023
Board Meeting Outcome for Outcome Of The Board Meeting Held On 11.11.2023 Pursuant To Regulation 30 Of SEBI (LODR) Regulations 2015
1. Approved the un-audited financial results for the quarter and year ended 30th September 2023. We attach herewith a copy of the reviewed un-audited financial results along with the limited review report. We are arranging to publish these results in the newspaper as per Regulation 47 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015

Dhanvantri Jeevan Rekha Ltd. Technical Scans

View details >>
Fri, 01 Dec 2023
Close Crossing Last Month High Close Crossing Last Month High
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Opening at High Opening at High
Closing Above Previous High Closing Above Previous High
Close Within 52 Week High Zone Close Within 52 Week High Zone

Dhanvantri Jeevan Rekha Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 295,418.12 1,231.25 +0.4%
Divi's Laboratories Ltd. 100,674.98 3,792.70 +0.1%
Cipla Ltd. 97,418.94 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. 95,866.76 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. 80,322.42 5,570.00 +0.7%
Mankind Pharma Ltd. 76,800.82 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. 72,809.77 2,151.30 +1.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.56 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-09 75.59 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-09 28.21 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.83 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 115.16 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 59.91 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 54.58 2,151.30 +1.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.94 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-09 7.94 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-09 3.92 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.76 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.36 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 9.11 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.86 2,151.30 +1.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 0.02 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,151.30 +1.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,151.30 +1.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,151.30 +1.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,151.30 +1.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,151.30 +1.1%

Dhanvantri Jeevan Rekha Ltd. FAQ's

What is DhanvantriJeevan Rek share price?
Can I buy DhanvantriJeevan Rek shares now?
What is the Market Cap of DhanvantriJeevan Rek?
What are the key metrics to analyse DhanvantriJeevan Rek?
What is the 52 Week High and Low of DhanvantriJeevan Rek?
What is the trend of DhanvantriJeevan Rek share price?